Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FMF50: a score for assessing outcome in familial Mediterranean fever.
Ozen S, Demirkaya E, Duzova A, Erdogan O, Erken E, Gul A, Kasapcopur O, Kasifoglu T, Kisacik B, Ozdogan H, Tunca M, Acikel C; FMF Arthritis Vasculitis and Orphan disease Research in pediatric rheumatology (FAVOR) and Turkish FMF study group. Ozen S, et al. Ann Rheum Dis. 2014 May;73(5):897-901. doi: 10.1136/annrheumdis-2013-204719. Epub 2014 Feb 25. Ann Rheum Dis. 2014. PMID: 24570027
Development of a medication adherence scale for familial Mediterranean fever (MASIF) in a cohort of Turkish children.
Yesilkaya S, Acikel C, Fidanci BE, Polat A, Sozeri B, Ayaz NA, Makay BB, Simsek D, Akinci N, Özçelik G, Kavukçu S, Emre S, Donmez O, Delibas A, Yüksel S, Berdeli A, Poyrazoglu H, Saldir M, Fidanci K, Çakar N, Peru H, Bakkaloglu S, Tabel Y, Sari O, Aydogan U, Ozenc S, Basbozkurt G, Unsal E, Kasapcopur Ö, Gok F, Ozen S, Demirkaya E; FMF Arthritis Vasculitis and Orphan disease Research in Paediatric Rheumatology (FAVOR). Yesilkaya S, et al. Among authors: ozcelik g. Clin Exp Rheumatol. 2015 Nov-Dec;33(6 Suppl 94):S156-62. Epub 2015 Sep 22. Clin Exp Rheumatol. 2015. PMID: 26393894
Outbreak of Shiga toxin-producing Escherichia-coli-associated hemolytic uremic syndrome in Istanbul in 2015: outcome and experience with eculizumab.
Ağbaş A, Göknar N, Akıncı N, Yıldırım ZY, Taşdemir M, Benzer M, Gökçe İ, Candan C, Küçük N, Uzuner S, Özçelik G, Demirkol D, Sever L, Çalışkan S. Ağbaş A, et al. Among authors: ozcelik g. Pediatr Nephrol. 2018 Dec;33(12):2371-2381. doi: 10.1007/s00467-018-4033-0. Epub 2018 Aug 29. Pediatr Nephrol. 2018. PMID: 30159625
Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter, retrospective study.
Taşdemir M, Canpolat N, Yıldız N, Özçelik G, Benzer M, Saygılı SK, Özkayin EN, Türkkan ÖN, Balat A, Candan C, Çelakıl M, Yavuz S, Akıncı N, Göknar N, Akgün C, Tülpar S, Alpay H, Sever FL, Bilge İ. Taşdemir M, et al. Among authors: ozcelik g. Turk J Med Sci. 2021 Aug 30;51(4):1781-1790. doi: 10.3906/sag-2012-297. Turk J Med Sci. 2021. PMID: 33581711 Free PMC article.
COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation.
Canpolat N, Yıldırım ZY, Yıldız N, Taşdemir M, Göknar N, Evrengül H, Gülmez R, Aksu B, Dursun H, Özçelik G, Yavaşcan Ö, Çiçek RY, Tülpar S, Hacıhamdioğlu DÖ, Nayır A, Alpay H. Canpolat N, et al. Among authors: ozcelik g. Eur J Pediatr. 2022 Jan;181(1):117-123. doi: 10.1007/s00431-021-04191-z. Epub 2021 Jul 3. Eur J Pediatr. 2022. PMID: 34218318 Free PMC article.
55 results